410
Views
27
CrossRef citations to date
0
Altmetric
CLINICAL STUDY

Increased Urinary Excretion of Monocyte Chemoattractant Protein-1 in Proteinuric Renal Diseases

, M.D., , M.D., , M.D., , M.D., , M.D., , M.D., , M.D., , M.D., , M.D. & , M.D. show all
Pages 439-444 | Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Anna Wasilewska, Walentyna Zoch-Zwierz, Katarzyna Taranta-Janusz & Zbigniew Kołodziejczyk. (2011) Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria. Scandinavian Journal of Urology and Nephrology 45:1, pages 52-59.
Read now
Hiroki Fujita, Jun Koshimura, Takehiro Sato, Takeshi Miura, Hiroshi Sasaki, Tsukasa Morii, Takuma Narita, Masafumi Kakei, Seiki Ito & Yuichiro Yamada. (2007) Effects of Long-Term Pravastatin Treatment on Serum and Urinary Monocyte Chemoattractant Protein-1 Levels and Renal Function in Type 2 Diabetic Patients with Normoalbuminuria. Renal Failure 29:7, pages 791-796.
Read now

Articles from other publishers (25)

Francesca Bianca Aiello, Franco Oreste Ranelletti, Marcella Liberatore, Paolo Felaco, Graziano De Luca, Alessia Lamolinara, Francesco Paolo Schena & Mario Bonomini. (2023) Independent Prognostic and Predictive Role of Interstitial Macrophages in Kidney Biopsies of IgA Nephropathy Patients. Journal of Personalized Medicine 13:6, pages 935.
Crossref
Yijie Jia, Jiaqi Chen, Zhikang Zheng, Yuan Tao, Shuting Zhang, Meina Zou, Yanlin Yang, Meng Xue, Fang Hu, Yang Li, Qian Zhang, Yaoming Xue & Zongji Zheng. (2022) Tubular epithelial cell-derived extracellular vesicles induce macrophage glycolysis by stabilizing HIF-1α in diabetic kidney disease. Molecular Medicine 28:1.
Crossref
Theodoros Ntrinias, Marios Papasotiriou, Lamprini Balta, Dimitra Kalavrizioti, Sotirios Vamvakas, Evangelos Papachristou & Dimitrios S. Goumenos. (2019) Biomarkers in Progressive Chronic Kidney Disease. Still a Long Way to Go. PRILOZI 40:3, pages 27-39.
Crossref
Fenqin Chen, Guozhu Wei, Yang Zhou, Xiaoyu Ma & Qiuyue Wang. (2019) The Mechanism of miR-192 in Regulating High Glucose-Induced MCP-1 Expression in Rat Glomerular Mesangial Cells. Endocrine, Metabolic & Immune Disorders - Drug Targets 19:7, pages 1055-1063.
Crossref
Radica Z. Alicic, Emily J. Johnson & Katherine R. Tuttle. (2018) Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease. Advances in Chronic Kidney Disease 25:2, pages 181-191.
Crossref
Alfons Segarra-Medrano, Clara Carnicer-Caceres, Naiara Valtierra-Carmeno, Irene Agraz-Pamplona, Natalia Ramos-Terrades, Elías Jatem Escalante & Elena Ostos-Roldan. (2017) Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type 1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy. Nefrología (English Edition) 37:5, pages 531-538.
Crossref
Alfons Segarra-Medrano, Clara Carnicer-Caceres, Naiara Valtierra-Carmeno, Irene Agraz-Pamplona, Natalia Ramos-Terrades, Elías Jatem Escalante & Elena Ostos-Roldan. (2017) Valor de los niveles urinarios de interleucina 6, factor de crecimiento epidérmico, proteína quimioatractante de monocitos de tipo 1 y factor de crecimiento transformante β1 para la predicción de la extensión de las lesiones de fibrosis en biopsias de enfermos con nefropatía IgA. Nefrología 37:5, pages 531-538.
Crossref
Chie Noiri, Taisuke Shimizu, Kaori Takayanagi, Yosuke Tayama, Takatsugu Iwashita, Shimpei Okazaki, Minoru Hatano, Osamu Matsumura, Hitoshi Kato, Akihiko Matsuda, Tetsuya Mitarai & Hajime Hasegawa. (2015) Clinical significance of fractional magnesium excretion (FEMg) as a predictor of interstitial nephropathy and its correlation with conventional parameters. Clinical and Experimental Nephrology 19:6, pages 1071-1078.
Crossref
Chelsey Pye, Nehal M. Elsherbiny, Ahmed S. Ibrahim, Gregory I. Liou, Ahmed Chadli, Mohamed Al-Shabrawey & Ahmed A. Elmarakby. (2014) Adenosine kinase inhibition protects the kidney against streptozotocin-induced diabetes through anti-inflammatory and anti-oxidant mechanisms. Pharmacological Research 85, pages 45-54.
Crossref
Rafael N. Moresco, Manuela B. Sangoi, José A.M. De Carvalho, Etiane Tatsch & Guilherme V. Bochi. (2013) Diabetic nephropathy: Traditional to proteomic markers. Clinica Chimica Acta 421, pages 17-30.
Crossref
Clarice Kazue Fujihara & Roberto Zatz. 2013. Seldin and Giebisch's The Kidney. Seldin and Giebisch's The Kidney 2933 2959 .
Jun Panee. (2012) Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes. Cytokine 60:1, pages 1-12.
Crossref
Ming-gang Wei & Wei sun. (2012) The regression equation for the patients with IgA nephropathy in clinical research. The regression equation for the patients with IgA nephropathy in clinical research.
Akosua Vilaysane, Justin Chun, Mark E. Seamone, Wenjie Wang, Rick Chin, Simon Hirota, Yan Li, Sharon A. Clark, Jurg Tschopp, Kiril Trpkov, Brenda R. Hemmelgarn, Paul L. Beck & Daniel A. Muruve. (2010) The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD. Journal of the American Society of Nephrology 21:10, pages 1732-1744.
Crossref
Agnès Matheson, Mark D. P. Willcox, Judith Flanagan & Bradley J. Walsh. (2010) Urinary biomarkers involved in type 2 diabetes: a review. Diabetes/Metabolism Research and Reviews 26:3, pages 150-171.
Crossref
William F. Finn & George A. Porter. 2008. Clinical Nephrotoxins. Clinical Nephrotoxins 92 130 .
Narayana S. Murali, Allan W. Ackerman, Anthony J. Croatt, Jingfei Cheng, Joseph P. Grande, Shari L. Sutor, Richard J. Bram, Gary D. Bren, Andrew D. Badley, Jawed Alam & Karl A. Nath. (2007) Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. American Journal of Physiology-Renal Physiology 292:2, pages F837-F844.
Crossref
Ju-young MoonLaeik JeongSangho LeeKyunghwan JeongTaewon LeeChun-Gyoo IhmJungho SuhJunghee KimYoo-yeon JungJoo-Ho Chung. (2007) Association of Polymorphisms in Monocyte Chemoattractant Protein-1 Promoter with Diabetic Kidney Failure in Korean Patients with Type 2 Diabetes Mellitus. Journal of Korean Medical Science 22:5, pages 810.
Crossref
Y.-M. Chen, S.-L. Lin, W.-C. Chiang, K.-D. Wu & T.-J. Tsai. (2006) Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases. Kidney International 69:8, pages 1410-1415.
Crossref
K.S. Eardley, D. Zehnder, M. Quinkler, J. Lepenies, R.L. Bates, C.O. Savage, A.J. Howie, D. Adu & P. Cockwell. (2006) The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney International 69:7, pages 1189-1197.
Crossref
Philip Janiak, Jean-Pierre Bidouard, Catherine Cadrouvele, Bruno Poirier, Laurent Gouraud, Yoann Grataloup, Françoise Pierre, Patrick Bruneval, Stephen Eric O'Connor & Jean-Marc Herbert. (2006) Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats. European Journal of Pharmacology 534:1-3, pages 271-279.
Crossref
Li Ren, Jason B. Blanchette, Lindsay R. White, Sharon A. Clark, Daniel J. Heffner, Lee Anne Tibbles & Daniel A. Muruve. (2005) Soluble fibronectin induces chemokine gene expression in renal tubular epithelial cells. Kidney International 68:5, pages 2111-2120.
Crossref
SANG-HO LEE, TAE WON LEE, CHUN-GYOO IHM, MYUNG JAE KIM, JEOUNG-TAEK WOO & JOO-HO CHUNG. (2005) Genetics of diabetic nephropathy in type 2 DM: candidate gene analysis for the pathogenic role of inflammation. Nephrology 10:s2, pages S32-S36.
Crossref
Zhong-Gao XuLinda LantingNosratola D. VaziriZhen LiLili SepassiBernardo Rodriguez-IturbeRama Natarajan. (2005) Upregulation of Angiotensin II Type 1 Receptor, Inflammatory Mediators, and Enzymes of Arachidonate Metabolism in Obese Zucker Rat Kidney. Circulation 111:15, pages 1962-1969.
Crossref
William F. Finn & George A. Porter. 2003. Clinical Nephrotoxins. Clinical Nephrotoxins 621 655 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.